Perhaps the use of CXCR4 antagonists, many of which are already in various stages of clinical development [93], and shown to significantly reduce lung metastasis in mouse models of osteosarcoma [94], would be a beneficial treatment option for patients with metastatic SS, particularly in cases where tumors are unresectable. The gene discussed is CXCR4; the disease is synovial sarcoma.